Get started
Author

Caterina Ilari

Comparative analysis between RQ‐PCR and digital‐droplet‐PCR of immunoglobulin/T‐cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia
2016 · Irene Della Starza, Vittorio Nunes, et al. · British Journal of Haematology · 69
PDF
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
2019 · Ilaria Del Giudice, Sara Raponi, et al. · Frontiers in Oncology · 55
PDF
Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia
2016 · Marilisa Marinelli, Caterina Ilari, et al. · Oncotarget · 50
PDF
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics
2018 · Gian Matteo Rigolin, Elena Saccenti, et al. · British Journal of Haematology · 45
PDF
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia
2019 · Irene Della Starza, Lucia Anna De Novi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 29
Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B‐cell receptor structure, function, and patients' prognosis
2013 · Ilaria Del Giudice, Sabina Chiaretti, et al. · American Journal of Hematology · 29
PDF
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations
2020 · Sara Raponi, Caterina Ilari, et al. · British Journal of Haematology · 25
PDF
Inter‐ and intra‐patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments
2015 · Ilaria Del Giudice, Marilisa Marinelli, et al. · British Journal of Haematology · 24
Genetic landscape of ultra-stable chronic lymphocytic leukemia patients
2018 · S. Raponi, I. Del Giudice, et al. · Annals of Oncology · 19
PDF
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study
2021 · Gian Matteo Rigolin, Ilaria Del Giudice, et al. · Blood · 16
PDF
Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients
2017 · Thomas Sau-Yan Chan, Yuh-Shan Lee, et al. · Oncotarget · 16
PDF
Biallelic BIRC 3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease
2018 · Sara Raponi, Ilaria Del Giudice, et al. · British Journal of Haematology · 14
PDF
Unravelling the suboptimal response of TP 53‐mutated chronic lymphocytic leukaemia to ibrutinib
2018 · Anna Guarini, Nadia Peragine, et al. · British Journal of Haematology · 10
PDF
Treatment with ibrutinib does not induce a TP53 clonal evolution in chronic lymphocytic leukemia
2021 · Luciana Cafforio, Sara Raponi, et al. · Haematologica · 9
PDF
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases
2022 · Roberta Soscia, Irene Della Starza, et al. · Hematological Oncology · 5
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile
2017 · I Del Giudice, G M Rigolin, et al. · Leukemia · 4
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV ‐D‐J rearrangements and BRAF ‐V600E mutation: lack of evidence for a common origin
2015 · Marzia Cavalli, Caterina Ilari, et al. · British Journal of Haematology · 4
PDF
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature
2023 · Ilaria Del Giudice, Luca Vincenzo Cappelli, et al. · British Journal of Haematology · 3
PDF
Comparative Analysis between RQ-PCR, Digital-Droplet-PCR and Next-Generation-Sequencing (NGS) of Immunoglobulin/T-Cell Receptor Gene Rearrangements to Monitor Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia Patients
2018 · Irene Della Starza, Lucia Anna De Novi, et al. · Blood · 3
Whole‐genome amplification for the detection of molecular targets and minimal residual disease monitoring in acute lymphoblastic leukaemia
2014 · Irene Della Starza, Lucia Anna De Novi, et al. · British Journal of Haematology · 3
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low‐risk chronic lymphocytic leukaemia patients
2023 · Gian Matteo Rigolin, Alice Traversa, et al. · British Journal of Haematology · 2
PDF
TP53 Clonal and Subclonal Architecture in Chronic Lymphocytic Leukemia Patients Under Ibrutinib Treatment
2018 · Ilaria Del Giudice, Luciana Cafforio, et al. · Blood · 1
Fludarabine, Cyclophosphamide, Ofatumumab (FC-O2) As Front-Line Treatment for Young and Fit Patients with Chronic Lymphocytic Leukemia (CLL): Preliminary Results of the Prospective Phase 2 LLC0911 Gimema Study
2015 · Francesca Romana Mauro, Francesco Zaja, et al. · Blood · 1
BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion
2014 · Ilaria Del Giudice, Silvia Bonina, et al. · Blood · 1
Genotype-Phenotype Predictive Gap in Pre-Emptive Screening of DPD Deficiency: Improving Sensitivity
2026 · Gerardo Salerno, Ottavia De Luca, et al. · Pharmaceuticals
Works count: 36
Citation count: 437
H-index: 12
I10-index: 13
Year
Topic
Type